|
Beyond the talking points:
Endpoints at JPM
JANUARY 12 - 13, 2026 | 7:00 AM - 5:00 PM PT
MARRIOTT MARQUIS, SAN FRANCISCO | HYBRID
The biopharma money has dried up, but the deals haven't stopped — they've just gotten harder. As the industry gathers in San Francisco for JPM, everyone's asking the same question: What actually works when capital is scarce and the old playbook is dead? Join Endpoints in SF — we're inviting you to the center of the action. Get the deep dive on JPM Monday and Tuesday, with real conversations from the leaders shaping biopharma's future. Need to work? The Endpoints Hub offers a premium coworking lounge, a place to escape the noise, compare notes with peers who get it, and figure out your next move over breakfast, lunch, and real conversation.
CHOOSE YOUR PASS Use code JPM26_LO to save on your in-person pass.
Join us in-person on Monday & Tuesday
Join us in-person on Monday or Tuesday
Includes 3 All-Access passes
The story behind the deals happening right now
John Carroll sits down with dealmakers from Amgen, PwC, and AbbVie to discuss the M&A surge that delivered multiple $10 billion acquisitions despite the broader downturn. They'll examine whether this momentum continues into 2026 or if buyers pull back. Which biotechs will survive, and which will become the next targets?
The executives steering biopharma through its toughest period are ready to share what they're seeing. Mike Doustdar, CEO of Novo Nordisk, took the helm as the obesity market Novo pioneered became increasingly competitive. After several months leading the Danish giant, he's sitting down with Drew Armstrong to discuss his vision for reclaiming Novo's edge. View the full agenda here.
Mike Doustdar
CEO, Novo Nordisk
Save 15% when you buy a group pass — plus you can assign names later on for your team- Virtual passes are available at no charge
Use code JPM26_LO to save on your in-person pass
RECENTLY ADDED: NETWORKING. INSIGHT.
A LIVE PODCAST TAPING. YOU IN?
In-person passes include access to our invite-only networking reception on Tuesday, Jan. 13, featuring drinks, light bites, and a live taping of Post-hoc Live with Executive Editor Drew Armstrong and special guest Noubar Afeyan, Founder and CEO of Flagship Pioneering. Join fellow passholders, industry peers, and Endpoints editors to debrief the week and connect before heading out. Reserve your in-person pass to Endpoints at JPM to receive your reception
invitation. Space is limited — RSVP required.
|